Siemens Healthineers Gains EUA For Clinitest Rapid COVID-19 Antigen Self-Test

Siemens Healthineers has received the FDA’s Emergency Use Authorization for its Clinitest rapid COVID-19 antigen self-test.

The nasal swab test, which provides test results in 15 minutes, is intended for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and up, and children age two to 13 with adult help, according to the Tarrytown, N.Y.-based subsidiary of the German tech giant.

Siemens Healthineers said it expects to make the test available in the U.S. this month and has “dedicated production capacity for U.S.-bound product in the tens of millions per month.”